Irani D, Heidari M
Departments of Urology, Faghihi and Namazi Hospitals, Shiraz University of Medical Sciences, Shiraz, Iran.
Urol J. 2004 Spring;1(2):107-10; discussion 110.
To evaluate the efficacy of modified Gil-Vernet anti-reflux surgery in the treatment of patients with primary vesicoureteral reflux in a prospective historical controlled trial.
A total of 30 patients with 46 refluxing units underwent this surgery since February 1998 until September 2002, with the mean follow-up period of 18 (range 6 to 43) months.
Vesicoureteral reflux was resolved completely in 44 ureteral units (95.6%, p<0001). In 2 refluxing units (4.3%) in spite of reflux improvement, hydroureter remained unchanged after the surgery. In respect to response rate, there was no significant difference between different grades, genders, age groups, and laterality of primary vesicoureteral reflux.
Our findings indicate that modified Gil-Vernet anti-reflux surgery which separately transfers each ureteral orifice to the tip of trigone with two fine absorbable suture on each side, is a completely successful procedure in the treatment of primary vesicoureteral reflux and produces a longer submucosal tunnel with a more suitable angel than classic Gil-Vernet procedure dose.
在一项前瞻性历史对照试验中评估改良吉尔 - 韦尔内抗反流手术治疗原发性膀胱输尿管反流患者的疗效。
自1998年2月至2002年9月,共有30例患者的46个反流单位接受了该手术,平均随访期为18(6至43)个月。
44个输尿管单位(95.6%,p<0.001)的膀胱输尿管反流完全消失。在2个反流单位(4.3%)中,尽管反流有所改善,但术后输尿管积水情况未变。在反应率方面,原发性膀胱输尿管反流的不同分级、性别、年龄组和双侧性之间无显著差异。
我们的研究结果表明,改良吉尔 - 韦尔内抗反流手术通过在两侧分别用两根细可吸收缝线将每个输尿管口转移至三角区尖端,是治疗原发性膀胱输尿管反流的完全成功的手术,且与经典吉尔 - 韦尔内手术相比,能产生更长的黏膜下隧道和更合适的角度。